Monograph Details
|
|
Central Nervous System
> Insomnia
|
|
DALMANE |
| Manufacturer |
|
Valeant Pharmaceuticals, Inc |
| Legal Classification |
|
CIV |
| Pharmacological Class |
|
Benzodiazepine. |
| Generic Name |
|
Flurazepam HCl 15mg, 30mg; caps. |
| Indications |
|
Insomnia. |
| Children |
|
<15yrs: not recommended. |
| Adults |
|
15–30mg at bedtime. Elderly or debilitated: initially 15mg at bedtime. |
| Contraindications |
|
Pregnancy. |
| Precautions |
|
Drug or alcohol abuse. Avoid prolonged use. Withdraw gradually. Suicidal tendencies. Depression. Pulmonary, renal, or hepatic disease. Nursing mothers: not recommended. |
| Interactions |
|
Potentiates CNS depression with alcohol and other CNS depressants. |
| Adverse Reactions |
|
CNS depression, complex sleep-related behaviors (eg, sleep-driving), ataxia, headache, GI upset, paradoxical excitement; blurred vision, anaphylaxis, angioedema. |
| How Supplied |
|
Caps—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
